Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Josep Dalmau(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Rita J. Balice‐Gordon(MC2 Therapeutics (Denmark)), Eugenia Martínez‐Hernández(Universitat Autònoma de Barcelona), Eric Lancaster(University of Pennsylvania), Myrna R. Rosenfeld(University of Pennsylvania)
Cited by 2,413
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
|The Lancet Neurology|2008|3.5k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
Paraneoplastic anti– <i>N</i> ‐methyl‐ <scp>D</scp> ‐aspartate receptor encephalitis associated with ovarian teratoma
|Annals of Neurology|2007|2.5k
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series
|The Lancet Neurology|2010|1.4k